✦ LIBER ✦

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

✍ Scribed by Vallerie V. McLaughlin; David B. Badesch; Marion Delcroix; Thomas R. Fleming; Sean P. Gaine; Nazzareno Galiè; J. Simon R. Gibbs; Nick H. Kim; Ronald J. Oudiz; Andrew Peacock; Steeve Provencher; Olivier Sitbon; Victor F. Tapson; Werner Seeger

Book ID: 119268328
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 350 KB
Volume: 54
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2009.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End points and clinical trial designs in

End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives

✍ Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila G Hawor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Exercise as an end-point in pulmonary hy

Exercise as an end-point in pulmonary hypertension trials

✍ B. McCullagh; R. E. Girgis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

The globalization of clinical trials in

The globalization of clinical trials in pulmonary arterial hypertension

✍ Myung H. Park; Lewis J. Rubin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Intermediate versus hard end points in c

Intermediate versus hard end points in clinical trials on hypertension

✍ Guido Grassi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 184 KB

Clinical perspective: biomarkers in pulm

Clinical perspective: biomarkers in pulmonary arterial hypertension

✍ G. A. Heresi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

642 Clinical Utility of Right Ventricula

642 Clinical Utility of Right Ventricular End-Diastolic Wall Stress in Pulmonary Arterial Hypertension

✍ A. Zhai; K. Addetia; D. Langleben; J. Therrien 📂 Article 📅 2012 🏛 Pulsus Group Inc 🌐 English ⚖ 129 KB